Clinical Trial Update: Benzonatate Dose Tolerance Study [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 dose-tolerance study of benzonatate to evaluate safety across increasing doses for cough.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• Benzonatate (BENZONATATE)

Snippet

Sponsor: Pfizer | Conditions: Cough | Phase 1 | Status: COMPLETED